Wu Haotian, Xie Xiang
Department of Interventional Radiology, The Second Affiliated Hospital of Anhui Medical University Heifei 230001, Anhui, China.
Am J Transl Res. 2024 Dec 15;16(12):7725-7733. doi: 10.62347/WXED3760. eCollection 2024.
To analyze the efficacy and influencing factors of percutaneous transhepatic cholangiography and biliary drainage (PTCD) in patients with malignant obstructive jaundice (MOJ).
The study included 151 MOJ patients admitted from January 2021 to January 2024. Seventy patients in the control group received endoscopic retrograde cholangiopancreatography (ERCP), while 81 patients in the research group underwent PTCD. Clinical outcomes, including surgical success rate, efficacy (overall remission, high- and low-level intestinal obstruction remission), safety (bile leakage, septicemia, hemobilia, pancreatitis, and gastrointestinal bleeding), and clinical-related indicators (hospital stay, surgical cost, treatment cost), as well as serum biochemical markers (alanine aminotransferase [ALT], direct bilirubin [DBIL], and total bilirubin [TBIL]), were compared between the groups. Binary logistic regression was used to identify factors influencing PTCD efficacy.
The surgical success rate was significantly higher in the research group than that in the control group (P < 0.05). Although the overall remission rates were similar between the groups (P > 0.05), the research group had a lower low-level intestinal obstruction remission rate and a higher high-level intestinal obstruction remission rate (P < 0.05). Safety profiles and changes in pre- and post-operative serum biochemical markers did not differ significantly between the groups (all P > 0.05). The research group experienced longer hospital stays and lower surgical costs compared to the control group (both P < 0.05), while treatment costs were similar (P > 0.05). Binary logistic regression identified obstruction site, and preoperative liver dysfunction as factors influencing PTCD efficacy.
PTCD demonstrated a higher surgical success rate than ERCP in MOJ patients, with comparable overall efficacy, safety, and treatment costs. PTCD was associated with longer hospital stays and lower surgical costs. Both procedures similarly improved ALT, DBIL, and TBIL levels. PTCD showed the greatest therapeutic benefit in cases of high-level intestinal obstruction.
分析经皮肝穿刺胆管造影及胆道引流术(PTCD)治疗恶性梗阻性黄疸(MOJ)患者的疗效及影响因素。
本研究纳入了2021年1月至2024年1月收治的151例MOJ患者。对照组70例患者接受内镜逆行胰胆管造影术(ERCP),研究组81例患者接受PTCD。比较两组的临床结局,包括手术成功率、疗效(总体缓解、高低位肠梗阻缓解)、安全性(胆漏、败血症、胆道出血、胰腺炎和胃肠道出血)及临床相关指标(住院时间、手术费用、治疗费用),以及血清生化标志物(丙氨酸氨基转移酶[ALT]、直接胆红素[DBIL]和总胆红素[TBIL])。采用二元逻辑回归分析确定影响PTCD疗效的因素。
研究组的手术成功率显著高于对照组(P<0.05)。虽然两组的总体缓解率相似(P>0.05),但研究组低位肠梗阻缓解率较低,高位肠梗阻缓解率较高(P<0.05)。两组的安全性及术前术后血清生化标志物变化无显著差异(均P>0.05)。与对照组相比,研究组住院时间更长,手术费用更低(均P<0.05),而治疗费用相似(P>0.05)。二元逻辑回归分析确定梗阻部位和术前肝功能不全为影响PTCD疗效的因素。
在MOJ患者中,PTCD的手术成功率高于ERCP,总体疗效、安全性和治疗费用相当。PTCD与更长的住院时间和更低的手术费用相关。两种手术均能同样改善ALT、DBIL和TBIL水平。PTCD在高位肠梗阻病例中显示出最大的治疗益处。